Skip to content

Contact
Careers

<img width="171" height="60" src="https://www.durect.com/wp-content/uploads/2022/06/Durect_logo.png" class="custom-logo" alt="Durect Logo Color" srcset="https://www.durect.com/wp-content/uploads/2022/06/Durect_logo.png 1x, https://www.durect.com/wp-content/uploads/2022/06/Durect_logo@2x.png 2x" />

About Us
Epigenetic Regulation
Clinical Development
Partnering & Technologies
Investors
Resources

<img width="171" height="60" src="https://www.durect.com/wp-content/uploads/2022/06/Durect_logo.png" class="custom-logo" alt="Durect Logo Color" srcset="https://www.durect.com/wp-content/uploads/2022/06/Durect_logo.png 1x, https://www.durect.com/wp-content/uploads/2022/06/Durect_logo@2x.png 2x" />

Investors hero

Events

Upcoming Events

More events coming soon

Past Events

1653390000 1653390000

H.C. Wainwright Global Investment Conference

May 24, 2022

Durect Corporation – First Quarter 2022 Earnings Call

May 4, 2022

Oppenheimer 32nd Annual Healthcare Conference

March 15, 2022

Investor Relations Contact

Contact: Michael Morabito, PhD

Solebury Trout

Tel: +1-646-378-2928

mmorabito@soleburytrout.com

Email Alerts Sign-Up

Email

SEC Filings

Press Releases

End of Day Stock Quote

About Us
Epigenetic Regulation
Clinical Development
Partnering & Technologies
Investors
Resources
- Publications
- Factsheets
Contact
Careers

About Us
Epigenetic Regulation
Clinical Development
Partnering & Technologies
Investors
Resources
- Publications
- Factsheets
Contact
Careers

Company

About Us
Leadership
Board of Directors
Partnering
Careers
Contact

Science

Epigenetic Regulation
Clinical Development
Pipeline
AH
NASH
Clinical Trials

Resources

Publications
Media Kit
Factsheets

Investors

Overview
Stock Information
FAQs
SEC Filings
Press Releases
Information Request

Copyright © 2022 Durect Corporation

Privacy Policy | Legal Notice | Accessibility

Scroll to Top